Solos posts 10 percent Q1 sales hike, but losses widen

May 26, 2010 by MassDevice staff

First-quarter sales rise 10 percent for Solos Endoscopy Inc., but Q1 losses widen by more than 68 percent.

SNDY logo

Solos Endoscopy Inc. (OTC:SNDY) posted a 10 percent sales increase for the first quarter, but saw its Q1 losses widen by 68.4 percent.

The Boston-based endoscopic instruments and imaging equipment maker posted sales of $105,000 for the three months ended March 31, compared with $95,000 during the same period last year.

But net losses widened to $297,000, up from $177,000 during Q1 2009.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.